Deskripsi
Clinical trial evidence for curcumin supplementation in ulcerative colitis management, summarizing remission rates and symptom improvement across published studies. Curcumin as adjunctive therapy is associated with higher clinical response rates compared to standard therapy alone.
Cite This Figure
![Figure 2: Clinical trial evidence for curcumin supplementation in ulcerative colitis management, summarizing remission rates and symptom improvement across published studies. Curcumin as adjunctive therapy is associated with higher clinical response rates compared to standard therapy alone.]() > Source: Aleksandra Pituch-Zdanowska et al. "Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.." *Nutrients*, 2022. PMID: [36558408](https://pubmed.ncbi.nlm.nih.gov/36558408/)
<figure> <img src="" alt="Clinical trial evidence for curcumin supplementation in ulcerative colitis management, summarizing remission rates and symptom improvement across published studies. Curcumin as adjunctive therapy is associated with higher clinical response rates compared to standard therapy alone." /> <figcaption>Figure 2. Clinical trial evidence for curcumin supplementation in ulcerative colitis management, summarizing remission rates and symptom improvement across published studies. Curcumin as adjunctive therapy is associated with higher clinical response rates compared to standard therapy alone.<br> Source: Aleksandra Pituch-Zdanowska et al. "Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36558408/">36558408</a></figcaption> </figure>